| Literature DB >> 35429789 |
Syed Ahsan Raza1, Xiaotao Zhang2, Abiodun Oluyomi3, Omolola E Adepoju4, Ben King5, Christopher I Amos6, Hoda Badr7.
Abstract
BACKGROUND: The COVID-19 pandemic during lockdown has highlighted the importance of identifying individuals most at risk of infection with SARS-CoV-2, underscoring the need to assess factors contributing to susceptibility to disease. With the rapidly evolving nature of the pandemic and its new variants, there is an inadequate understanding on whether there are certain factors such as a specific symptom or collection of symptoms that combined with life-style behaviors may be useful to predict susceptibility. The study aims to explore such factors from pre-vaccination data to guide public health response to potential new waves.Entities:
Keywords: COVID-19; Infections; Population survey; Predictors; Susceptibility
Mesh:
Year: 2022 PMID: 35429789 PMCID: PMC8941860 DOI: 10.1016/j.jiph.2022.03.012
Source DB: PubMed Journal: J Infect Public Health ISSN: 1876-0341 Impact factor: 7.537
Univariate analysis of demographics, contact history and lifestyle factorsa.
| COVID-19 Negative (n = 130) | COVID-19 Perceived as Susceptible (n = 130) | OR (95% CI) | |
|---|---|---|---|
| n (%) | n (%) | ||
| DEMOGRAPHICS | |||
| Age | 22 (16.9) | 26 (20.0) | Ref |
| Gender | 100 (76.9) | 65 (50.4) | Ref |
| Education level | 92 (70.8) | 81 (62.3) | Ref |
| Race/ethnicity | 98 (79.0) | 64 (50.0) | Ref |
| Annual Income | |||
| CONTACT HISTORY & LIFESTYLE FACTORS | |||
| Contact History | 112 (86.8) | 91 (70.5) | Ref |
| Alcohol drinking | 48 (52.7) | 54 (49.1) | Ref |
| Tobacco smoking | 72 (79.1) | 64 (58.2) | Ref |
Column percentages are from total of yes and no answers.
CI:Confidence Interval.
Univariate analysis of clinical symptoms and comorbid conditionsa.
| COVID-19 | COVID-19 | OR (95% CI) | |
|---|---|---|---|
| n (%) | n (%) | ||
| Constitutional symptoms | |||
| Fever | 4 (16.1) | 21(28.0) | 23.7 (3.1, 82.3) |
| Headache | 16 (25.8) | 21 (28.0) | 1.1 (0.5, 2.4) |
| Body aches | 21 (33.9) | 16 (21.3) | 0.5 (0.2, 1.1) |
| Fatigue/tiredness | 8 (12.9) | 5 (6.7) | 0.5 (1.5, 1.6) |
| Respiratory symptoms | |||
| Cough | 18 (29.0) | 54 (72.0) | 1.9 (0.9, 3.9) |
| Shortness of breath | 24 (38.7) | 33 (44.0) | 0.9 (0.5, 1.9) |
| Runny nose | 14 (22.6) | 28 (37.3) | 1.4 (0.7, 3.1) |
| Sore throat | 19 (30.6) | 19 (25.3) | 0.8 (0.4, 1.6) |
| Loss of smell or taste | 15 (24.2) | 14 (18.7) | 0.7 (0.3, 1.6) |
| Comorbidity | |||
| Cancer | 18 (13.8) | 25 (19.2) | 1.5 (0.8, 2.9) |
| Heart disease | 3 (2.8) | 6 (5.6) | 2.1 (0.5, 8. 5) |
| Chronic lung disease | 15 (13.4) | 16 (14.7) | 1.1 (0.5, 2.4) |
| Diabetes | 4 (13.7) | 19 (16.8) | 5.3 (1.7, 16.0) |
| Autoimmune diseases | 11 (9.9) | 13 (11.7) | 1.2 (0.5, 2.8) |
| Intestinal diseases | 6 (5.5) | 12 911.1) | 2.2 (0.8, 6.0) |
Column percentages are from total of yes and no answers
CI:Confidence Interval.
Fig. 1(a and b) AUROC for COVID-19 Perceived Susceptibility using combination of different (a) constitutional symptoms and (b) respiratory symptoms. AUROC values are presented in parenthesis.
Predictive models for COVID-19 Perceived susceptibility adjusted for symptoms, demographics, and lifestyle behavior.
| Model I | Model II | Model III | ||||
|---|---|---|---|---|---|---|
| OR (95%CI) | p | OR (95%CI) | p | OR (95%CI) | p | |
| Fever | 32.7 (4.1, 89.2) | 0.001 | 34.8 (4.1, 85.1) | 0.001 | 33.5 (3.9, 85.9) | 0.001 |
| Body aches | 3.1 (1.2, 7.6) | 0.016 | 2.9 (1.1, 7.6) | 0.019 | 3.0 (1.1, 8.0) | 0.026 |
| Contact history | 2.6 (1.1, 5.7) | 0.016 | 2.7 (1.2, 6.5) | 0.019 | 2.7 (1.1, 6.4) | 0.027 |
| Age > 50 years | 3.0 (1.1,8.6) | 0.037 | 2.5 (0.9, 6.8) | 0.072 | ||
| Smokers | 3.3 (1.2, 9.1) | 0.022 | ||||
| AUROC | 0.752 | 0.788 | 0.803 | |||
Models adjusted for other symptoms: headache, cough shortness of breath, rhinorrhea, and sore throat and comorbid conditions.